Patient Management Following an Early Diagnosis: Options and Key Considerations
James Leverenz, MD, emphasizes the value of early diagnosis of Alzheimer’s disease alongside the current clinical management options for patients with the early stages of Alzheimer’s disease after a diagnosis.
Key Learning Objectives for Biogen’s ADPD 2019 Symposium:
- Understand the importance of an accurate and timely diagnosis of Alzheimer’s disease
- Review the diagnostic challenges of a mixed pathology in patients with Alzheimer’s disease
- Increase understanding of how comprehensive clinical assessments and a range of imaging and fluid biomarkers can be used in the timely diagnosis of a complex case of Alzheimer’s disease
- Raise awareness of the current healthcare system readiness for a paradigm shift to early diagnosis of Alzheimer’s disease
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.